Zymeworks (NASDAQ:ZYME) reported quarterly losses of $(0.59) per share. This is a 96.67 percent decrease over losses of $(0.30) per share from the same period last year. The company reported $2.408 million in sales this quarter. This is a 91.12 percent decrease over sales of $27.110 million the same period last year.